Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFaron Pharmaceuticals Share News (FARN)

Share Price Information for Faron Pharmaceuticals (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 98.50
Bid: 97.00
Ask: 100.00
Change: 0.50 (0.51%)
Spread: 3.00 (3.093%)
Open: 98.00
High: 98.50
Low: 98.00
Prev. Close: 98.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: BiVictriX expands development; Okyo wins US patent

Wed, 23rd Feb 2022 20:11

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Begbies Traynor Group PLC - Manchester-based corporate rescue and recovery company - Says its third quarter which ended January 31 had performed broadly in line with the first half. As a result, Begbies Traynor expects the full-year to be within the range of market expectations and significantly ahead of last year. Current market expectations for pretax profit are in the range of GBP17.0 million to GBP18.5 million. Reports insolvency numbers have returned to pre-pandemic levels due to increased liquidations.

----------

Gooch & Housego PLC - Somerset, England-based photonics company - Reports strong and improving levels of overall demand in the first four months of its financial year which ends September 30. The company reports a record order book of GBP110.5 million at January 31, up 16% from GBP95.0 million at the same time the previous year. Notes high demand for industrial lasers. Expects trading to have a slightly higher second half weighting than anticipated but says full-year outlook remains unchanged.

----------

Great Western Mining Corp PLC - London-based mineral exploration and development company with operations in the US - Says 51 mineralised spoil heaps have now been located at Mineral Jackpot in Nevada, US. Notes average grades of vein material of 1.57 grams per tonne of gold and average grades of altered wall rock of 0.04 grams per tonne of gold. Says spoil heaps were composed of average 5% vein material and 50% altered wall rock. Chair Brian Hall calls the results "highly encouraging".

----------

Union Jack Oil PLC - Bath, England-based oil and gas company with operations across the UK - Says it intends to adopt a capital allocation and distribution policy to allow the payment of a dividend or implement a share repurchase programme. This comes as a result of its current performance, principally at the Wressle development, the company explains.

----------

BiVictriX Therapeutics PLC - Cheshire, England-based biotechnology company - Expands its therapeutic pipeline with two additional programmes, BVX002 and BVX003. BVX002 and BVX003 target novel cancer-specific twin antigen fingerprints and enable the targeting of several haematological and solid tumour cancer indications. Both are entering the early stages of drug development.

----------

Okyo Pharma Ltd - London-based biopharmaceutical company focused on eye diseases and ocular pain - Receives patent from the US Patent & Trademark Office covering OK-101 to treat neuropathic pain. OK-101 is the company's anti-inflammatory drug being developed to treat dry eye disease. Adds the drug is expected to begin a phase two clinical trial in the fourth quarter of 2022.

----------

Faron Pharmaceuticals Ltd - Turku, Finland-based biopharmaceutical company - Announces updated survival data from its phase one/two study investigating the safety and efficacy of bexmarilimab. Bexmarilimab is an investigative immunotherapy with the potential to provide immune stimulation for difficult-to-treat cancers, Faron explains. Study demonstrates an estimated median progression free survival of 59 days and an estimated median overall survival of 157 days. Chief Medical Officer Marie-Louise Fjallskog says the data shows late-stage cancer patients who receive clinical benefit from bexmarilimab can "achieve long term survival".

----------

Chesterfield Resources PLC - London-based gold and copper company operating in Canada and Cyprus - Says drilling at its Troodos West project in Cyprus has significantly enhanced the prospectivity at three target areas, Orchard, Evlim and Evlim South, and has also established a 12 kilometre geological trend that the company considers key to controlling several mineralised systems. Adds that this 12 kilometre trend, named the Westline Trend, will now be the focus of its 2022 exploration campaign, due to commence shortly.

----------

Invinity Energy Systems PLC - London-based energy storage company - Wins GBP708,371 of funding from the UK Department for Business, Energy & Industrial Strategy for the Longer Duration Energy Storage Demonstration competition. The award will fund a comprehensive planning and feasibility study on what Invinity says could become one of the UK's largest co-located solar and energy storage projects. Work on the phase one feasibility study has already commenced and is expected to progress throughout 2022, the company adds.

----------

Technology Minerals PLC - London-based battery metals company - Says its wholly-owned subsidiary, Technology Minerals Cameroon Ltd, has applied for five exploration permits in Cameroon. The company says it has now received copies of all these permits and has instructed Technology Minerals Cameroon's legal counsel to verify the validity of the permits.

----------

Sanderson Design Group PLC - Buckinghamshire, England-based luxury interior furnishings company - Announces that its brand Morris & Co is launching a second collection of fabrics and wallpapers in collaboration with architect and designer Ben Pentreath. The collection will launch in March.

----------

Mirriad Advertising PLC - London-based advertising company - Signs partnership with unnamed company which it describes as "Canada's largest TV and digital media conglomerate". Says the partnership is strategically important for the North American market. Does not disclose financial details of the partnership. Mirriad adds that US campaign revenues were up by over 800% during the 2021 holiday season compared to 2020.

----------

SEEEN PLC - London-based AI-focused media platform - Forms strategic partnership with Auckland-based media intelligence platform Kinetiq Inc. The companies plan to provide "end-to-end" solutions for brands, networks and publishers to better manage and measure audience experiences, SEEEN explains.

----------

Cohort PLC - Reading, England-based - Says that its SEA subsidiary has been appointed to supply its torpedo launcher systems to South Korea-based ship building company Hyundai Heavy Industries Co Ltd. Says the multi-million pound contract will see the first Philippine Navy corvette delivered in 2023 and the second in 2025.

----------

Arena Events Group PLC - St Ives, England-based events management company - Acquisition by IHC Industiral Holding LLC and Tasheel Holding Group LLC completes. Shares in Arena were subsequently suspended.

----------

Drax Group PLC - Yorkshire, England-based power generation company - Provisionally secures agreements to provide 621 megawatts of capacity from its pumped storage and hydro assets. Drax says agreements are at the price of GBP30.59 per kilowatt for the period between October 2025 to September 2026. Expects income of GBP18 million for that period. Adds these agreements are in addition to its existing agreements.

----------

Power Metal Resources PLC - London-based metals exploration company focused in North America, Africa and Australia - Says that First Development Resources Ltd, a company in which Power Metal holds a 83% interest, has received notification from the Northern Territory Government Department of Industry, Tourism & Trade that all three Selta project mineral exploration licences have now been granted for a term of six years. The Selta project is located in Australia's Northern Territory and has been declared prospective for uranium mineralisation.

----------

Curzon Energy PLC - London-based energy company - Refinances and extends the outstanding loan between itself and Redcar, England-based chemical recycling company Poseidon Plastics Ltd. On February 3, a loan agreement of GBP500,000 was made available and due for repayment on February 14. Companies agree to increase the size of the loan facility by GBP245,000 and to refinance all outstanding amounts to February 14, 2023.

----------

Schroder UK Public Private Trust PLC - London-based investment company - Says its portfolio company Atom Bank has raised more than GBP75 million in new equity priced at 70 pence per share. Says this aids company as it grows its profitability and drives towards an IPO. The impact of the funding round will also be reflected in Schroder's next net asset value update, due in April.

----------

Amur Minerals Corp - Khabarovsk, Russia-based nickel copper sulphide mineral exploration company focused in Russia - Says that there is no impact on its operations or activities within Russia following a review of UK and US sanction documentation. Adds that no individual or entity identified within the documents is associated with the company in any way.

----------

Pembridge Resources PLC - London-based mining company with operations in Canada - Says Minto Metals Corp, a company it acquired in 2019, has received a new exploration permit. The 10-year class four quartz mining land use permit was granted by the Yukon Government in Canada. The permit enables Minto to diamond drilling, geophysical surveys and other associated exploration land-use activities on its mining claims, including the Minto Mine property. Adds that Minto has recently approved a CAD9.2 million - around USD7.2 million - exploration programme for 2022.

----------

Avon Protection PLC - Wiltshire, England-based respiratory protection equipment company - Reports that Non-Executive Director Bruce Thompson buys 5,000 shares at a price of GBP10.089 each. Purchase totals GBP50,445.

----------

By Heather Rydings; heatherrydings@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
12 Jul 2019 10:20

Faron Pharma Pleased By MATINS Progress And Plans To Increase Capacity

(Alliance News) - Faron Pharmaceuticals Oy said on Friday its MATINS study of nine cancer patients is progressing well, and it is planning to expand the clinical trial to more countries.The

Read more
26 Jun 2019 11:52

Faron Pharmaceuticals Says Traumakine Study Hindered By Steroid Use

(Alliance News) - Faron Pharmaceuticals Oy on Wednesday said interim results from its phase two Inforaaa study support continuation but the study is limited by a lack of patients not also taking a

Read more
14 Jun 2019 11:54

Faron Pharmaceuticals' Analysis Explains "Disappointing" Prior Trial

(Alliance News) - Faron Pharmaceuticals Oy on Friday said analysis of a more recent trial of Traumakine has explained why the drug did not perform as expected in a previous trial.Shares in

Read more
14 Jun 2019 10:37

Faron Pharmaceuticals reports 'significant' findings from YODA study

(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals announced results from its pharmacokinetic/dynamic 'YODA' study examining the administration of concomitant steroids and Traumakine in healthy volunteers on Friday.

Read more
24 May 2019 13:34

Faron Pharma Finance Head Wichmann Steps Down, Hanninen Replaces

LONDON (Alliance News) - Faron Pharmaceuticals Oy on Friday said it has made several managerial changes, which it believes will strengthen its operating performance.The clinical stage said

Read more
24 May 2019 11:50

Faron appoints new CFO after some internal shuffling

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals updated the market on its board and management team on Friday, announcing that Yrjö Wichmann was leaving his current role as its chief financial officer to take up the new position of vice-president, financing and investor relations.

Read more
14 May 2019 14:16

Faron Pharmaceuticals Raises EUR1.3 Million Via Share Subscription (ALLISS)

LONDON (Alliance News) - Biopharmaceutical company Faron Pharmaceuticals Ltd said Tuesday that it has raised EUR1.3 million via share subscription.The company has issued 1.8 million shares

Read more
7 May 2019 11:44

Faron Pharmaceuticals Narrows Loss On Reduced Clinical Trial Costs

LONDON (Alliance News) - Faron Pharmaceuticals Ltd on Tuesday reported a slightly narrowed annual loss as the drug developer's research & development costs fell.Faron is a clinical

Read more
2 May 2019 17:30

Faron Pharmaceuticals Knows Of No Reason For 43% Share Price Jump

LONDON (Alliance News) - Faron Pharmaceuticals Ltd on Thursday said it is unable to explain the recent movement in its share price.Faron noted Thursday's 43% share price rise, and said

Read more
30 Apr 2019 16:02

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 1 May J SainsburyFull Year ResultsConnect GroupHalf Year GroupQ1 Stock

Read more
29 Apr 2019 15:46

Faron Gets Results Of Traumakine Study From Japanese Licensing Partner

LONDON (Alliance News) - Faron Pharmaceuticals Oy on Monday said its Japanese licensing partner Maruishi Pharmaceutical Co Ltd has provided clinical trial results on its phase three Traumakine for

Read more
11 Apr 2019 12:13

Faron Pharmaceuticals To Focus On Colorectal Cancer In Clevegen Trial

LONDON (Alliance News) - Faron Pharmaceuticals Oy is to target colorectal cancer in its upcoming test programme for Clevegen, it said Thursday.The testing of Clevegen on patients with will

Read more
11 Apr 2019 11:22

Faron Pharmaceuticals upbeat on latest info from MATINS trial

(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals announced on Thursday that the cohort expansion part of its phase 1 and 2 'MATINS' clinical trial, investigating the safety and efficacy of its wholly-owned novel precision cancer immunotherapy 'Clevegen', would begin with patients suffering from late-stage colorectal cancer as soon as the optimal dosing was determined.

Read more
26 Mar 2019 15:52

UPDATE: Faron Pharmaceuticals Raises EUR3.1 Million In Fundraise (ALLISS)

LONDON (Alliance News) - Finland's Faron Pharmaceuticals Oy on Tuesday afternoon said it has raised EUR3.1 million pursuant to a placing announced earlier in the day.The company issued

Read more
26 Mar 2019 12:05

Faron Pharmaceuticals Optimistic For Traumakine As It Plans Fundraise (ALLISS)

LONDON (Alliance News) - Finland's Faron Pharmaceuticals Oy on Tuesday said it expects further disappointing results from Traumakine, as it plans a share placing.Faron is currently for

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.